Sun Pharmaceutical Industries Limited's Board met on 22 May 2025, approving the audited standalone and consolidated financial results for the quarter and year ended 31 March 2025.
A final dividend of ₹5.50 per equity share of Re. 1 each has been recommended, subject to shareholder approval at the AGM. The record date for the dividend is set for Monday, 07 July 2025, with payment on or before Friday, 08 August 2025.
Ms. Vidhi Shanghvi has been appointed as a Whole-time Director for five years, effective 22 May 2025, pending shareholder approval.
Mr. Sudhir Valia is retiring from his position as Non-executive and Non-independent Director and will not seek reappointment at the upcoming AGM.
M/s. KJB & CO LLP has been appointed as the Secretarial Auditors for five years, from the conclusion of the 33rd AGM until the conclusion of the 38th AGM, subject to shareholder approval.
The 33rd Annual General Meeting will be held on Thursday, 31 July 2025, at 4:00 P.M. IST via videoconferencing.
The Board of Directors recommended a final dividend of ₹ 5.50 per equity share of ₹ 1 each in addition to the interim dividend of ₹ 10.50 per equity share declared on January 31, 2025.
Audited standalone financial results for the year ended March 31, 2025: